Dublin, March 30, 2023 (GLOBE NEWSWIRE) -- The "Interventional Oncology Devices Global Market Report 2023" report has been added to ResearchAndMarkets.com's offering.
This report provides strategists, marketers and senior management with the critical information they need to assess the market.
The global interventional oncology devices market will grow from $2.21 billion in 2022 to $2.35 billion in 2023 at a compound annual growth rate (CAGR) of 6.4%. The interventional oncology devices market is expected to grow from $3.03 billion in 2027 at a CAGR of 6.5%.
Companies Mentioned
- Boston Scientific Corporation
- Medtronic plc
- Terumo Corporation
- Merit Medical Systems, Inc.
- Philips Volcano
- AngioDynamics Inc.
- GE Healthcare
- Siemens Healthineers
- Sirtex Medical
- Cook Medical Incorporated
Reasons to Purchase
- Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
- Understand how the market has been affected by the coronavirus and how it is responding as the impact of the virus abates.
- Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
- Measure the impact of high global inflation on market growth.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on the latest market shares.
- Benchmark performance against key competitors.
- Suitable for supporting your internal and external presentations with reliable high quality data and analysis
The interventional oncology devices market consists of sales of embolization devices, ablation devices, and support devices. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
Interventional oncology devices are used in the diagnosis and treatment of cancer using minimally invasive techniques and advanced imaging technology.
North America was the largest region in the interventional oncology devices market in 2022. Asia Pacific was the second largest region in the interventional oncology devices market. The regions covered in the interventional oncology devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa.
The main products of interventional oncology devices are embolization devices, ablation devices, and support devices. The embolization devices are intended for the embolization of the blood vessels of a variety of tumors. The interventional oncology devices are used to perform procedures such as thermal tumor ablation, non-thermal tumor ablation, transcatheter arterial chemoembolization (TACE), transcatheter arterial radioembolization (TARE), or selective internal radiation therapy (SIRT), and transcatheter arterial embolization (TAE), or bland embolization that are used to treat cancer types such as liver cancer, kidney cancer, lung cancer, bone cancer, and others.
The availability of private and government funding drove the interventional oncology devices market. In the field of cancer, funding from the government and private has increased, especially for the devices used in treatments as it promotes early detection and better survival rates.
The American Cancer Society, the largest non-government, not-for-profit cancer research funder, has awarded 630 projects with a grant amount of $384,262,652 in 2021. BioProtect Ltd, an Israeli company that develops novel bioabsorbable polymer spacer balloons, received a funding of $13 million of its Series D equity financing from a leading global syndicate of venture investors that finances the ongoing multicenter FDA clinical trial of BioProtect's lead product, the ProSpace balloon spacer, which protects prostate cancer patients undergoing radiation therapy.
Endosight, the first augmented-reality-guided ablative system, has received 20% of its funding from private organizations. The funding from government and private organizations helps in the development of new technologies and devices, thereby driving the interventional oncology devices market.
Rising product recalls are likely to hinder the demand for interventional oncology devices. The number of interventional oncology product recalls has risen. For instance, in June 2020, the IceFORCE 2.1 CX Prostate Cryoablation Kit Visual ICE System of the Boston Scientific Corporation was recalled as the needle surface had deteriorated. In March 2020, Medtronic recalled the Pipeline Flex embolization system with Shield technology due to a fracture in the distal portion. These product recalls put financial strain on businesses and also hampers the demand, thus hindering the market.
Companies are focusing on deploying robotics technology in interventional oncology devices, for higher efficiency. The robotic system integrates image-based planning and navigation with the installation of different instruments to the desired body part with better accuracy and efficiency. For instance, in March 2022, the U.S. Food and Drug Administration approved Quantum Surgical's Epione interventional oncology robotics platform.
The countries covered in the interventional oncology devices market are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, and USA.
Key Topics Covered:
1. Executive Summary
2. Interventional Oncology Devices Market Characteristics
3. Interventional Oncology Devices Market Trends And Strategies
4. Interventional Oncology Devices Market - Macro Economic Scenario
4.1 COVID-19 Impact On Interventional Oncology Devices Market
4.2 Ukraine-Russia War Impact On Interventional Oncology Devices Market
4.3 Impact Of High Inflation On Interventional Oncology Devices Market
5. Interventional Oncology Devices Market Size And Growth
5.1. Global Interventional Oncology Devices Historic Market, 2017-2022, $ Billion
5.1.1. Drivers Of The Market
5.1.2. Restraints On The Market
5.2. Global Interventional Oncology Devices Forecast Market, 2022-2027F, 2032F, $ Billion
5.2.1. Drivers Of The Market
5.2.2. Restraints On the Market
6. Interventional Oncology Devices Market Segmentation
6.1. Global Interventional Oncology Devices Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- Embolization Devices
- Ablation Devices
- Support Devices
6.2. Global Interventional Oncology Devices Market, Segmentation By Procedure, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- Thermal Tumor Ablation
- Non-thermal Tumor Ablation
- Transcatheter Arterial Chemoembolization (TACE)
- Transcatheter Arterial Radioembolization (TARE) or Selective Internal Radiation Therapy (SIRT)
- Transcatheter Arterial Embolization (TAE) or Bland Embolization
6.3. Global Interventional Oncology Devices Market, Segmentation By Cancer Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- Liver Cancer
- Kidney Cancer
- Lung Cancer
- Bone Cancer
- Other Cancer Types
7. Interventional Oncology Devices Market Regional And Country Analysis
7.1. Global Interventional Oncology Devices Market, Split By Region, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
7.2. Global Interventional Oncology Devices Market, Split By Country, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
For more information about this report visit https://www.researchandmarkets.com/r/dl1iza
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
